Artemis Medicare Services Ltd
- Market Cap ₹ 3,757 Cr.
- Current Price ₹ 269
- High / Low ₹ 350 / 208
- Stock P/E 39.4
- Book Value ₹ 63.8
- Dividend Yield 0.17 %
- ROCE 14.9 %
- ROE 12.9 %
- Face Value ₹ 1.00
Pros
- Company has delivered good profit growth of 32.5% CAGR over last 5 years
Cons
- Stock is trading at 4.21 times its book value
- Company has a low return on equity of 11.7% over last 3 years.
- Promoters have pledged or encumbered 44.5% of their holding.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of BSE Healthcare BSE SmallCap BSE Allcap
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 261 | 368 | 402 | 459 | 503 | 547 | 563 | 402 | 545 | 714 | 845 | 913 | 981 | |
| 234 | 325 | 359 | 406 | 442 | 480 | 501 | 367 | 477 | 620 | 717 | 763 | 818 | |
| Operating Profit | 27 | 43 | 43 | 53 | 60 | 66 | 62 | 35 | 68 | 94 | 128 | 150 | 163 |
| OPM % | 11% | 12% | 11% | 11% | 12% | 12% | 11% | 9% | 12% | 13% | 15% | 16% | 17% |
| 1 | 3 | 5 | 4 | 3 | 2 | 4 | 7 | 3 | 7 | 7 | 33 | 36 | |
| Interest | 13 | 12 | 9 | 9 | 9 | 11 | 13 | 12 | 11 | 19 | 30 | 30 | 29 |
| Depreciation | 9 | 12 | 12 | 15 | 18 | 20 | 22 | 21 | 21 | 29 | 38 | 43 | 44 |
| Profit before tax | 7 | 21 | 27 | 32 | 35 | 37 | 32 | 9 | 39 | 53 | 68 | 109 | 126 |
| Tax % | 0% | 12% | 21% | 16% | 24% | 44% | 36% | 20% | 16% | 25% | 28% | 24% | |
| 7 | 19 | 22 | 27 | 27 | 21 | 20 | 7 | 33 | 40 | 49 | 83 | 95 | |
| EPS in Rs | 0.32 | 0.88 | 1.03 | 1.29 | 1.27 | 0.98 | 1.54 | 0.54 | 2.46 | 2.96 | 3.62 | 6.07 | 6.90 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 15% | 12% | 7% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 10% |
| 3 Years: | 19% |
| TTM: | 12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 32% |
| 3 Years: | 36% |
| TTM: | 47% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 76% |
| 3 Years: | 53% |
| 1 Year: | -5% |
| Return on Equity | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 10% |
| 3 Years: | 12% |
| Last Year: | 13% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 21 | 21 | 21 | 21 | 21 | 0.00 | 13 | 13 | 13 | 13 | 14 | 14 | 14 |
| Reserves | 116 | 135 | 163 | 183 | 210 | 280 | 301 | 308 | 348 | 393 | 438 | 828 | 873 |
| 110 | 85 | 68 | 94 | 91 | 114 | 108 | 137 | 190 | 268 | 305 | 280 | 274 | |
| 66 | 90 | 93 | 124 | 130 | 160 | 159 | 130 | 145 | 207 | 191 | 221 | 255 | |
| Total Liabilities | 313 | 331 | 345 | 422 | 452 | 555 | 581 | 589 | 697 | 882 | 948 | 1,343 | 1,416 |
| 236 | 239 | 249 | 283 | 309 | 381 | 387 | 372 | 476 | 584 | 699 | 729 | 780 | |
| CWIP | 0 | 0 | 1 | 27 | 43 | 49 | 56 | 81 | 64 | 95 | 33 | 40 | 37 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 4 | 6 | 12 | 15 | 15 | 15 |
| 77 | 91 | 94 | 112 | 100 | 124 | 137 | 132 | 152 | 192 | 200 | 559 | 584 | |
| Total Assets | 313 | 331 | 345 | 422 | 452 | 555 | 581 | 589 | 697 | 882 | 948 | 1,343 | 1,416 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 45 | 53 | 20 | 58 | 72 | 41 | 56 | 27 | 61 | 129 | 108 | 139 | |
| -12 | -10 | -14 | -74 | -67 | -50 | -22 | -34 | -106 | -153 | -90 | -388 | |
| -21 | -35 | -24 | 19 | -10 | 14 | -33 | 13 | 44 | 30 | -26 | 277 | |
| Net Cash Flow | 11 | 7 | -18 | 3 | -4 | 5 | 2 | 6 | -2 | 7 | -8 | 28 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 41 | 39 | 49 | 48 | 40 | 52 | 50 | 48 | 47 | 43 | 36 | 37 |
| Inventory Days | 26 | 26 | 21 | 19 | ||||||||
| Days Payable | 237 | 195 | 189 | 187 | ||||||||
| Cash Conversion Cycle | -171 | -129 | -120 | -120 | 40 | 52 | 50 | 48 | 47 | 43 | 36 | 37 |
| Working Capital Days | -70 | -59 | -31 | -44 | -53 | -51 | -36 | -35 | -25 | -45 | -29 | -29 |
| ROCE % | 8% | 14% | 15% | 16% | 15% | 14% | 11% | 4% | 10% | 11% | 14% | 15% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
14h - Audio recording of Q2 & H1 FY26 earnings call posted on website, Nov 12, 2025.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 14h
-
Announcement under Regulation 30 (LODR)-Change in Management
1d - Q2/H1 Sep 30, 2025 results: H1 revenue Rs53,432.28L, H1 net profit Rs5,138.17L; internal auditor appointed Nov12,2025.
-
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
1d - Monitoring report Q2 FY26 (Sep 30, 2025): Rs330 crore CCDs; Rs61.94cr utilized; Rs268.11cr parked in FDs.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
1d - Q2 FY2025-26 consolidated revenue Rs27,470 Lacs; PAT Rs3,000 Lacs; Raipur unit targeted March 2026.
Annual reports
Concalls
-
Nov 2025TranscriptNotesPPT
-
Aug 2025TranscriptNotesPPT
-
May 2025TranscriptNotesPPT
-
Feb 2025TranscriptNotesPPT
-
Nov 2024TranscriptNotesPPT
-
Aug 2024TranscriptNotesPPT
-
May 2024TranscriptNotesPPT
-
Feb 2024TranscriptNotesPPT
-
Feb 2024TranscriptNotesPPT
-
Nov 2023TranscriptNotesPPT
-
Aug 2023TranscriptNotesPPT
-
May 2023TranscriptNotesPPT
-
Feb 2023TranscriptNotesPPT
-
Nov 2022TranscriptNotesPPT
Business Profile[1]
Promoted by Apollo Tyres Group, Artemis Medicare Services Ltd manages multi-specialty hospitals in Haryana under the brand Artemis Hospitals. The company provides a comprehensive range of advanced medical and surgical services across specialties such as cardiology, oncology, orthopedics, neurology, nephrology, gastroenterology, and critical care.